OTLK is trading 7.8% up now at $1.58 after two weak sessions and recent volatility around the $1.50–$1.70 range. No fresh company-specific news, earnings, FDA updates, or major analyst calls have been reported this morning, so the move looks like a rebound in a thinly traded small-cap biotech rather than a reaction to a specific headline.